Stocks Amgen Inc

More

  • We are at the beginning of a slow and uneven recovery but we will see the S&P 500 reach 1,000 by year-end, said Bob Doll, vice chairman of BlackRock.

  • yoshikami_michael_100_2011.jpg

    Investors have a new variable that could potentially impact investment outcomes -- the flu. Your portfolio strategy will be impacted depending on how serious the spread of swine flu is and how dramatic the resulting panic turns out to be.

  • graphic_word_ofthe_street.jpg

    The Dow and S&P fell on Wednesday after Morgan Stanley revived concerns about the health of both the banking sector and the wider economy...

  • CNBC’s Mike Huckman is keeping a close eye on Big Pharma earnings. And he suggests you do the same - because he's spotted a devil the details.

  • graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Victory for vernakalant! No, that's not German. It's the scientific, generic name of the experimental heart rhythm maintenance drug at a little Canadian company called Cardiome. The announcement came out Wednesday evening that Merck is hooking up with CRME in yet another partnership deal between big pharma and baby biotech.

  • Stock and options traders are piling into Biogen Idec on speculation that the drug maker could be a takeover target. About 75,000 options contracts traded on the name, more than 10 times the average over the last 20 session...

  • Stocks fell Monday amid doubts over the health of the banking industry and the apparent collapse of a major deal in the technology sector.

  • graphic_word_ofthe_street.jpg

    Stocks rose on Friday for the 4th day in a row, with the Dow closing out its best four-week winning streak since 1933.

  • On a week dominated by news in the autos sector, President Obama and the G20 summit; all major indexes closed positive on Friday, and up over 3% or greater for the week, led by the Russell 2000 with a weekly gain of 6.32%.

  • Bull_wall_street_front_200.jpg

    "This is a really big moment," says one investment pro.  "The real question in my mind is if we are dragging the floor up."

  • Those who forget the past are doomed NOT to repeat it.

  • In a week dominated by outrage over Wall Street bonuses, TALF funding, and the Fed buying government debt, the markets managed to maintain a positive weekly gain for the second consecutive week, running with all indexes up about 1% or greater. 

  • The face of Wall Street undoubtedly changed forever last fall, with the Lehman Brothers bankruptcy, the Bank of America acquisition of Merrill Lynch, the government’s unprecedented 79.9% stake in AIG, and the shift of major investment banks (like Goldman Sachs and Morgan Stanley) to become bank holding companies. However, before all those stunning events unfolded in the fall, exactly 1 year ago today, JPMorgan Chase agreed to acquire Bear Stearns for $236 million or $2 per share – signifying the end to one of Wall Street’s most storied franchises.

  • graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Stocks rose for the third day straight on Thursday, marking the biggest three-day gain since November. Markets were up across the board, led by Bank of America and General Electric.

  • The IBB biotech ETF is drawing strong options activity Thursday, as news ranging from mergers to government regulation continues to rock the sector.

  • Cramer makes the call on viewers' favorite stocks.

  • The final form of health-care reform is hardly clear, but Joel Sendek of Lazard Capital Markets says he's heard enough to point him toward some rewarding stock-market investments.

  • pharma_new3.jpg

    Even though nearly every analyst this morning is saying Thursday's bloodbath was an overreaction, investors are continuing to sell biopharma stocks in the early going Friday.